Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
83.80
-1.69 (-1.97%)
Oct 1, 2026, 3:57 PM EDT - Market open
Mirum Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $137 | Buy | Reiterates | $137 | +63.49% | Sep 29, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $123 → $130 | Buy | Maintains | $123 → $130 | +55.14% | Sep 29, 2026 |
| Citi | Citi | Buy Maintains $145 → $160 | Buy | Maintains | $145 → $160 | +90.94% | Sep 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $140 | Buy | Maintains | $140 | +67.07% | Sep 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $154 | Buy | Reiterates | $154 | +83.78% | Sep 29, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $140 → $195 | Buy | Reiterates | $140 → $195 | +132.71% | Sep 28, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $136 | Buy | Maintains | $136 | +62.30% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.